Literature DB >> 15716272

Structural basis for the cell-specific activities of the NGFI-B and the Nurr1 ligand-binding domain.

Ralf Flaig1, Holger Greschik, Carole Peluso-Iltis, Dino Moras.   

Abstract

NGFI-B is a ligand-independent orphan nuclear receptor of the NR4A subfamily that displays important functional differences with its homolog Nurr1. In particular, the NGFI-B ligand-binding domain (LBD) exhibits only modest activity in cell lines in which the Nurr1 LBD strongly activates transcription. To gain insight into the structural basis for the distinct activation potentials, we determined the crystal structure of the NGFI-B LBD at 2.4-angstroms resolution. Superimposition with the Nurr1 LBD revealed a significant shift of the position of helix 12, potentially caused by conservative amino acids exchanges in helix 3 or helix 12. Replacement of the helix 11-12 region of Nurr1 with that of NGFI-B dramatically reduces the transcriptional activity of the Nurr1 LBD. Similarly, mutation of Met414 in helix 3 to leucine or of Leu591 in helix 12 to isoleucine (the corresponding residues found in NGFI-B) significantly affects Nurr1 transactivation. In comparison, swapping the helix 11-12 region of Nurr1 into NGFI-B results in a modest increase of activity. These observations reveal a high sensitivity of LBD activity to changes that influence helix 12 positioning. Furthermore, mutation of hydrophobic surface residues in the helix 11-12 region (outside the canonical co-activator surface constituted by helices 3, 4, and 12) severely affects Nurr1 transactivation. Together, our data suggest that a novel co-regulator surface that includes helix 11 and a specifically positioned helix 12 determine the cell type-dependent activities of the NGFI-B and the Nurr1 LBD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716272     DOI: 10.1074/jbc.M413175200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  FHL2 protein is a novel co-repressor of nuclear receptor Nur77.

Authors:  Kondababu Kurakula; Erik van der Wal; Dirk Geerts; Claudia M van Tiel; Carlie J M de Vries
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

2.  6-Mercaptopurine augments glucose transport activity in skeletal muscle cells in part via a mechanism dependent upon orphan nuclear receptor NR4A3.

Authors:  Qinglan Liu; Xiaolin Zhu; Lusheng Xu; Yuchang Fu; W Timothy Garvey
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-10       Impact factor: 4.310

3.  Orphan nuclear receptor TR3/Nur77 differentially regulates the expression of integrins in angiogenesis.

Authors:  Taiyang Ye; Jin Peng; Xin Liu; Shiqiang Hou; Gengming Niu; Yan Li; Huiyan Zeng; Dezheng Zhao
Journal:  Microvasc Res       Date:  2018-11-01       Impact factor: 3.514

4.  DLL4 and Jagged1 are angiogenic targets of orphan nuclear receptor TR3/Nur77.

Authors:  Jin Peng; Shengqiang Zhao; Yan Li; Gengming Niu; Chen Chen; Taiyang Ye; Dezheng Zhao; Huiyan Zeng
Journal:  Microvasc Res       Date:  2019-03-28       Impact factor: 3.514

5.  Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.

Authors:  Marcia I Dawson; Mao Ye; Xihua Cao; Lulu Farhana; Qiong-Ying Hu; Yong Zhao; Li Ping Xu; Alice Kiselyuk; Ricardo G Correa; Li Yang; Tingjun Hou; John C Reed; Pamela Itkin-Ansari; Fred Levine; Michel F Sanner; Joseph A Fontana; Xiao-Kun Zhang
Journal:  ChemMedChem       Date:  2009-07       Impact factor: 3.466

6.  Ligand dissociation from estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.

Authors:  Milton T Sonoda; Leandro Martínez; Paul Webb; Munir S Skaf; Igor Polikarpov
Journal:  Mol Endocrinol       Date:  2008-04-10

7.  SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death.

Authors:  Long Zhang; Feng Xie; Juan Zhang; Peter Ten Dijke; Fangfang Zhou
Journal:  Cell Death Differ       Date:  2017-06-16       Impact factor: 15.828

8.  Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion.

Authors:  Anna-Maria Ordelheide; Felicia Gerst; Oliver Rothfuss; Martin Heni; Carina Haas; Inga Thielker; Silke Herzberg-Schäfer; Anja Böhm; Fausto Machicao; Susanne Ullrich; Norbert Stefan; Andreas Fritsche; Hans-Ulrich Häring; Harald Staiger
Journal:  Mol Metab       Date:  2013-06-17       Impact factor: 7.422

9.  Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.

Authors:  Syng-Ook Lee; Xi Li; Erik Hedrick; Un-Ho Jin; Ronald B Tjalkens; Donald S Backos; Li Li; Yi Zhang; Qiao Wu; Stephen Safe
Journal:  Mol Endocrinol       Date:  2014-08-06

10.  Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77.

Authors:  Lily C Chao; Kevin Wroblewski; Zidong Zhang; Liming Pei; Laurent Vergnes; Olga R Ilkayeva; Shi Ying Ding; Karen Reue; Matthew J Watt; Christopher B Newgard; Paul F Pilch; Andrea L Hevener; Peter Tontonoz
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.